drugset

drugset / Trial / NCT01012531

Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass Pollen

NCT01012531 ↗

Phase 3 Completed 121 enrolled Roxall

RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to assess the efficacy and safety of cluster immunotherapy with highly polymerized allergen extracts.

Timeline

Start: 2008-10
Primary completion: 2009-11
Completion: 2009-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	CLUSTOID	Unknown	—	Subcutaneous

Indications